AU8987198A - Product comprising at least a double stranded rna combined with at least a 6-benzyluracil derivative - Google Patents

Product comprising at least a double stranded rna combined with at least a 6-benzyluracil derivative

Info

Publication number
AU8987198A
AU8987198A AU89871/98A AU8987198A AU8987198A AU 8987198 A AU8987198 A AU 8987198A AU 89871/98 A AU89871/98 A AU 89871/98A AU 8987198 A AU8987198 A AU 8987198A AU 8987198 A AU8987198 A AU 8987198A
Authority
AU
Australia
Prior art keywords
product
benzyluracil
derivative
double stranded
stranded rna
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU89871/98A
Inventor
Eric Ruhlmann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ipsen Pharma SAS
Original Assignee
Societe de Conseils de Recherches et dApplications Scientifiques SCRAS SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Societe de Conseils de Recherches et dApplications Scientifiques SCRAS SAS filed Critical Societe de Conseils de Recherches et dApplications Scientifiques SCRAS SAS
Publication of AU8987198A publication Critical patent/AU8987198A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)

Abstract

The invention concerns a product comprising at least a double stranded RNA combined with at least a 6-benzyluracil derivative to be used in therapy simultaneously, separately or spread over time. Said product can be optionally combined with another antiviral agent. Said products are particularly useful for treating AIDS (Acquired Immuno Deficiency Syndrome).
AU89871/98A 1997-08-04 1998-08-03 Product comprising at least a double stranded rna combined with at least a 6-benzyluracil derivative Abandoned AU8987198A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9709974A FR2766711B1 (en) 1997-08-04 1997-08-04 PRODUCT COMPRISING AT LEAST ONE DOUBLE-STRANDED RNA IN ASSOCIATION WITH AT LEAST ONE DEVIRE OF 6-BENZYLURACIL FOR SIMULTANEOUS THERAPEUTIC USE, SEPARATE OR SPREAD OVER TIME
FR9709974 1997-08-04
PCT/FR1998/001726 WO1999007384A1 (en) 1997-08-04 1998-08-03 Product comprising at least a double stranded rna combined with at least a 6-benzyluracil derivative

Publications (1)

Publication Number Publication Date
AU8987198A true AU8987198A (en) 1999-03-01

Family

ID=9510012

Family Applications (1)

Application Number Title Priority Date Filing Date
AU89871/98A Abandoned AU8987198A (en) 1997-08-04 1998-08-03 Product comprising at least a double stranded rna combined with at least a 6-benzyluracil derivative

Country Status (10)

Country Link
EP (1) EP1001789B1 (en)
AT (1) ATE227132T1 (en)
AU (1) AU8987198A (en)
DE (1) DE69809246T2 (en)
DK (1) DK1001789T3 (en)
ES (1) ES2187056T3 (en)
FR (1) FR2766711B1 (en)
NO (1) NO20000554D0 (en)
PT (1) PT1001789E (en)
WO (1) WO1999007384A1 (en)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4950652A (en) * 1987-03-23 1990-08-21 Hem Research, Inc. dsRNAs for combination therapy in the treatment of viral diseases

Also Published As

Publication number Publication date
ES2187056T3 (en) 2003-05-16
WO1999007384A1 (en) 1999-02-18
EP1001789B1 (en) 2002-11-06
FR2766711B1 (en) 2001-02-02
NO20000554L (en) 2000-02-03
DK1001789T3 (en) 2003-03-10
ATE227132T1 (en) 2002-11-15
DE69809246D1 (en) 2002-12-12
DE69809246T2 (en) 2003-08-28
FR2766711A1 (en) 1999-02-05
PT1001789E (en) 2003-03-31
EP1001789A1 (en) 2000-05-24
NO20000554D0 (en) 2000-02-03

Similar Documents

Publication Publication Date Title
ZA200201511B (en) 3(5)-amino-pyrazole derivatives, process for their preparation and their use as antitumor agents.
MXPA02001497A (en) 3(5)-ureido-pyrazole derivatives, process for their preparation and their use as antitumor agents.
WO1998016507A3 (en) New heterocyclylmethyl-substituted pyrazol derivates and their use for treating cardiovascular diseases
EP0960107A4 (en)
PL336580A1 (en) Fine-molecular compounds useful in treating inflammatory diseases
HK1028594A1 (en) Adamantane derivatives
IL136369A0 (en) Adamantane derivatives
ZA9710098B (en) Halogenopyrimidines.
ZA975212B (en) Compositions of modified carbon products and amphiphilic ions and methods of using the same.
AU6878894A (en) 1-benzenesulfonyl-1,3-dihydro-2H-benzimidazol-2-one derivatives
ZA9711317B (en) Substituted purine derivatives, processes for their preparation, their use, and compositions comprising them.
AU2158601A (en) Antiviral agent for use in treatment of cancer
ZA976549B (en) Acryloyl substituted distamycin derivatives, process for preparing them, and their use as antitumor and antiviral agents.
ZA973883B (en) Distamycin derivatives, process for preparing them, and their use as antitumor and antiviral agents.
HK1040980A1 (en) Biphenylsulfonylcyanamides,process for their preparation, and their use as medicament
MY128260A (en) Cyclopentane-and-pentene-b-amino acids
AU5892399A (en) 1, 2, 4-triazole-3-thione compounds
ZA9610460B (en) New phenylamidine derivatives, processes for preparing them and their use as pharmaceutical compositions.
AU7552098A (en) Physiologically active substances tkr2449, process for producing the same, and microorganism
CA2003213A1 (en) Antimycotically active cyclopropyl-substituted azolylmethylcarbinols
AU1944799A (en) Hyperhydrated citicoline, process and use
AU8987198A (en) Product comprising at least a double stranded rna combined with at least a 6-benzyluracil derivative
EP1011329A4 (en) 7-methylthiooxomethyl and 7-methylthiodioxomethyl paclitaxels
AU4777997A (en) Ion pairs, process for producing the same and their use as contrast agents
MXPA01012500A (en) Gene therapy products.

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase